coformycin has been researched along with formycins in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calabresi, P; Crabtree, GW; Cummings, FJ; Jordan, M; LaBresh, K; Spremulli, EN | 1 |
Calabresi, P; Chu, SH; Crabtree, GW; Dexter, DL; Diamond, I; Farineau, DM; Ghoda, LY; McGowan, DL; Parks, RE; Spremulli, EN | 1 |
Hidaka, T; Katayama, K; Ohno, M; Shimazaki, M; Takeuchi, T; Umezawa, H; Watanabe, K; Yamashita, K; Yamashita, T | 1 |
Dancer, JE; Dudfield, PJ; Earnshaw, CG; Hewitt, BD; Lindell, SD; Moloney, BA | 1 |
4 other study(ies) available for coformycin and formycins
Article | Year |
---|---|
Hemodynamic effects of potentially useful antineoplastic agents.
Topics: Adenosine; Adenosine Deaminase Inhibitors; Animals; Antineoplastic Agents; Coformycin; Dose-Response Relationship, Drug; Electrocardiography; Female; Formycins; Hemodynamics; Hypotension; Pentostatin; Rats; Rats, Inbred Strains; Vidarabine Phosphate | 1983 |
Biochemical pharmacology and toxicology of formycin alone and in combination with 2'-deoxycoformycin (pentostatin).
Topics: Adenosine Deaminase Inhibitors; Animals; Antibiotics, Antineoplastic; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Blood Urea Nitrogen; Coformycin; Creatine; Drug Synergism; Female; Formycins; Lethal Dose 50; Liver; Male; Mice; Mice, Mutant Strains; Mice, Nude; Pentostatin; Rats; Ribonucleosides | 1983 |
Effects of a new adenosine deaminase inhibitor, isocoformycin, on toxicity, antitumor activity and tissue distribution of formycin A and 9-beta-D-arabinofuranosyladenine.
Topics: Adenosine Deaminase Inhibitors; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Coformycin; Drug Synergism; Female; Formycins; Mice; Nucleoside Deaminases; Ribonucleosides; Tissue Distribution; Vidarabine | 1980 |
The design and synthesis of inhibitors of adenosine 5'-monophosphate deaminase.
Topics: Adenosine; Adenosine Triphosphate; AMP Deaminase; Coformycin; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Formycins; Herbicides; Inhibitory Concentration 50; Phosphorylation; Purine Nucleosides; Ribonucleosides; Structure-Activity Relationship | 1999 |